Reason, E. H., Thomas, S. M., Chanenchuk, T., Botty van den Bruele, A., DiNome, M. L., Hwang, E. S., … Rosenberger, L. H. (2025). ASO Visual Abstract: Neoadjuvant Chemotherapy is Not Associated with Improved Overall Survival in Metaplastic Breast Cancer Regardless of Tumor Subtype. Ann Surg Oncol. https://doi.org/10.1245/s10434-025-18181-0

Reason, Ellery H., Samantha M. Thomas, Tori Chanenchuk, Astrid Botty van den Bruele, Maggie L. DiNome, E Shelley Hwang, Kendra Modell Parrish, et al. “ASO Visual Abstract: Neoadjuvant Chemotherapy is Not Associated with Improved Overall Survival in Metaplastic Breast Cancer Regardless of Tumor Subtype.” Ann Surg Oncol, August 26, 2025. https://doi.org/10.1245/s10434-025-18181-0.

Reason EH, Thomas SM, Chanenchuk T, Botty van den Bruele A, DiNome ML, Hwang ES, et al. ASO Visual Abstract: Neoadjuvant Chemotherapy is Not Associated with Improved Overall Survival in Metaplastic Breast Cancer Regardless of Tumor Subtype. Ann Surg Oncol. 2025 Aug 26;

Reason, Ellery H., et al. “ASO Visual Abstract: Neoadjuvant Chemotherapy is Not Associated with Improved Overall Survival in Metaplastic Breast Cancer Regardless of Tumor Subtype.” Ann Surg Oncol, Aug. 2025. Pubmed, doi:10.1245/s10434-025-18181-0.

Reason EH, Thomas SM, Chanenchuk T, Botty van den Bruele A, DiNome ML, Hwang ES, Parrish KM, Wang T, Plichta JK, Thomas A, Chiba A, Rosenberger LH. ASO Visual Abstract: Neoadjuvant Chemotherapy is Not Associated with Improved Overall Survival in Metaplastic Breast Cancer Regardless of Tumor Subtype. Ann Surg Oncol. 2025 Aug 26;